{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-019977","form_type":"8-K/A","ticker":"MNKD","cik":"0000899460","company_name":"MANNKIND CORP","filed_at":"2023-05-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:42.728870+00:00","generated_at":"2026-06-15T07:39:32.080743+00:00","sec_items":["9.01","2.02"],"event_type":"earnings","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"MannKind Q1 2023 revenues jump 239% to $41M; loss from ops down 72%","bullets":["Total revenues $40.6M, +239% vs Q1 2022; Tyvaso DPI contributed $23M (services + royalties).","Afrezza net revenue $12.4M (+26% YoY); V-Go added $5.1M after Q2 2022 acquisition.","Loss from operations narrowed 72% to $6M; commercial product gross margin 69%.","Cash and investments $166.6M at March 31, 2023; R&D spend up to $5.6M for pipeline.","CEO cites strong Tyvaso DPI demand; Phase 2/3 inhaled clofazimine trial planned H2 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-019977","json":"https://secwatch.observer/filing/0000950170-23-019977.json","markdown":"https://secwatch.observer/filing/0000950170-23-019977.md","text":"https://secwatch.observer/filing/0000950170-23-019977.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/899460/000095017023019977/0000950170-23-019977-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/899460/000095017023019977/mnkd-20230509.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T07:39:32.080743+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a1ac7dc0d5599d4a9149b53354f7b09e055fc65e","claim":"MANNKIND CORP reported the quarter ended March 31, 2023 results: revenue $41 million.","evidence_excerpt":"1Q 2023 Total Revenues of $41 million; +239% vs. 1Q 2022","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/899460/000095017023019977/0000950170-23-019977-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended March 31, 2023"},{"label":"Revenue","value":"$41 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}